Details

Autor(en) / Beteiligte

• Gamiño-Arroyo, Ana Estela
• Arellano-Galindo, José
• Del Carmen Guerra-de-Blas, Paola
• Ortega-Villa, Ana M.
• Mateja, Allyson
• Llamosas-Gallardo, Beatriz
• Ortíz-Hernández, Ana A.
• Valdéz-Vázquez, Rafael
• Ramírez-Venegas, Alejandra
• Galindo-Fraga, Arturo
• Guerrero, Ma Lourdes
• Ramos-Cervantes, Pilar
• Mendoza-Garcés, Luis
• González-Matus, Mónica
• Marroquín-Rojas, Carmen
• Xicohtencatl-Cortes, Juan
• Ochoa, Sara A.
• Cruz-Córdova, Ariadna
• Powers, John H.
• Ruiz-Palacios, Guillermo Miguel
• Beigel, John
• Moreno-Espinosa, Sarbelio

Titel

Clinical and molecular characterization of children and adults with respiratory bocavirus infection in Mexico: a cross-sectional nested study within the ILI002 prospective observational study

Ist Teil von

• Lancet Regional Health - Americas (Online), 2024-01, Vol.29, p.100647-100647, Article 100647

Ort / Verlag

England: Elsevier Ltd

Erscheinungsjahr

2024

Link zum Volltext

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Human Bocaviruses (HBoV) can cause acute respiratory tract infections. High coinfection rates cloud its pathogenicity. This study sought to describe the clinical features of HBoV1 disease in children and adults with Influenza-like illness (ILI), exploring associations between viral load, clinical features, and seasonality. Patients who tested positive for HBoV1 by polymerase chain reaction, enrolled from April 2010 to March 2014 in the ILI002 prospective observational cohort study were included in this cross-sectional nested study. Participants were included in ILI002 if they presented with signs and/or symptoms suggestive of influenza-like illness. Samples were tested for viral load, and NP1 and VP1/VP2 phylogenetic analyses, except for the samples lacking suitable and viable clinical material for genotyping. We identified HBoV1 in 157 (2.8%) of participants. Prevalence was 4.5% in children and 1.8% in adults. Single HBoV1 detection occurred in 41.1% and 46.3% of children and adults, respectively. Children commonly experienced fever (83.3%), cough with sputum (74.4%), and shortness of breath (72.2%). In the multivariate analysis of children, significant positive associations were detected between viral loads and age (0.20 [95% CI: 0.07, 0.33]), and the presence of fever (2.64 [95% CI: 1.35, 3.94]), nasal congestion (1.03 [95% CI: 0.07, 1.99]), dry cough (1.32 [95% CI: 0.42, 2.22]), chest congestion (1.57 [95% CI: 0.33, 2.80]), red eyes (1.25 [95% CI: 0.35, 2.14]), cough with sputum (1.79 [95% CI: 0.80, 2.78]), and other signs and symptoms such as chills, dizziness, and diaphoresis (1.73 [95% CI: 0.19, 3.27]). In contrast, significant negative associations were found between viral loads and percent neutrophils on the blood count (−0.04 [95% CI: −0.06, −0.02]), fatigue (−1.60 [95% CI: −2.46, −0.74]) and the presence of other symptoms or signs, including adenopathy and rash (−1.26 [95% CI: −2.31, −0.21]). Adults commonly experienced sore throat (73.1%), fatigue (77.4%), and headache (73.1%). In the multivariate analysis of adults, significant positive associations were detected between viral load and body mass index (0.13 [95% CI: 0.04, 0.21]), and the presence of confusion (1.54 [95% CI: 0.55, 2.53]), and sore throat (1.03 [95% CI: 0.20, 1.85]), and significant negative associations were detected between viral load and chest congestion (−1.16 [95% CI: −2.07, −0.24]). HBoV1 was detected throughout the year irrespective of season, temperature, and humidity. This study demonstrated the importance of detecting HBoV1 in patients with influenza-like illness either as single infection or co-infection, in both adults and children, and improves the characterization of HBoV1 seasonality, clinical features, and viral load. Phylogenetic analyses show a high conservation. The Mexican Emerging Infectious Diseases Clinical Research Network (LaRed), CONACYT (Fondo Sectorial SSA/IMSS/ISSSTE, Projects No. 71260 and No. 127088), Fondos federales no. HIM/2015/006, NIAID, NIH through a contract with Westat, Inc. (HHSN2722009000031, HHSN27200002), NCI, NIH (75N91019D00024, 75N91019F00130). Additional information at the end of the manuscript.